Matches in Wikidata for { <http://www.wikidata.org/entity/Q96827396> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q96827396 description "article scientifique publié en 2020" @default.
- Q96827396 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q96827396 description "im Juli 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q96827396 description "scientific article published on 01 July 2020" @default.
- Q96827396 description "wetenschappelijk artikel" @default.
- Q96827396 description "наукова стаття, опублікована 1 липня 2020" @default.
- Q96827396 name "A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma" @default.
- Q96827396 name "A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma" @default.
- Q96827396 type Item @default.
- Q96827396 label "A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma" @default.
- Q96827396 label "A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma" @default.
- Q96827396 prefLabel "A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma" @default.
- Q96827396 prefLabel "A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma" @default.
- Q96827396 P1433 Q96827396-CB24CCB3-8D52-41AE-8937-07CF73F26A51 @default.
- Q96827396 P1476 Q96827396-168C3FE1-AB6E-4EBF-BC6C-DBE077E8A1E1 @default.
- Q96827396 P2093 Q96827396-1CEA869B-78B1-47DE-B3B4-077487843571 @default.
- Q96827396 P2093 Q96827396-281DCB2C-34B0-4D99-AAFB-572EFDC4854D @default.
- Q96827396 P2093 Q96827396-789E7DD2-2827-47E3-9719-6C0C723134AF @default.
- Q96827396 P2093 Q96827396-7ECB3DD0-6B88-4EB4-90DB-55317883CBEA @default.
- Q96827396 P2093 Q96827396-9FC72114-6BEB-492D-A6E8-DF94F3E7FE14 @default.
- Q96827396 P2093 Q96827396-A358AB6A-E02F-4BDB-9F64-CAD63736037F @default.
- Q96827396 P2093 Q96827396-B0A51F89-AF75-4E73-BB91-23C451A2E75A @default.
- Q96827396 P2093 Q96827396-B4340D1F-71E6-4945-B83D-EEC14DFE90C8 @default.
- Q96827396 P2093 Q96827396-B619BE0F-958B-4E9C-B796-2FA96945351B @default.
- Q96827396 P2093 Q96827396-B7A33034-818E-44DE-9D7E-8905C203809B @default.
- Q96827396 P2093 Q96827396-F266F5A9-2299-4631-981C-E6C016DDC68A @default.
- Q96827396 P2093 Q96827396-F67BE02C-6408-4DFE-AB5F-6C1C8A2824E0 @default.
- Q96827396 P275 Q96827396-31abeaa9-fc2a-4556-9bb7-7bd888eaa905 @default.
- Q96827396 P31 Q96827396-7A634309-D750-451C-ADAD-A06F3617D9DB @default.
- Q96827396 P356 Q96827396-F08F3B71-D18C-4175-A8C6-784C0C050E00 @default.
- Q96827396 P50 Q96827396-F8A4F39D-1C23-4A2E-93B2-7A89655A69C1 @default.
- Q96827396 P577 Q96827396-0FB2F47C-ABC3-4AE4-A965-54FE4AA51A46 @default.
- Q96827396 P6216 Q96827396-f518046b-be4f-4486-8d5d-5415b53b743c @default.
- Q96827396 P698 Q96827396-C6D451FF-2F2E-43F9-981C-C08A291462F1 @default.
- Q96827396 P932 Q96827396-91730EFF-17CF-44D9-83C2-22C392D3D355 @default.
- Q96827396 P356 THEONCOLOGIST.2020-0610 @default.
- Q96827396 P698 32608142 @default.
- Q96827396 P1433 Q2122327 @default.
- Q96827396 P1476 "A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma" @default.
- Q96827396 P2093 "Anne S Tsao" @default.
- Q96827396 P2093 "Bonnie S Glisson" @default.
- Q96827396 P2093 "Carl M Gay" @default.
- Q96827396 P2093 "Don L Gibbons" @default.
- Q96827396 P2093 "George R Simon" @default.
- Q96827396 P2093 "J Jack Lee" @default.
- Q96827396 P2093 "John V Heymach" @default.
- Q96827396 P2093 "Merrill S Kies" @default.
- Q96827396 P2093 "Renata Ferrarotto" @default.
- Q96827396 P2093 "Wei Lu" @default.
- Q96827396 P2093 "Xi Ming Tang" @default.
- Q96827396 P2093 "Yanhong Zhou" @default.
- Q96827396 P275 Q24082749 @default.
- Q96827396 P31 Q13442814 @default.
- Q96827396 P356 "10.1634/THEONCOLOGIST.2020-0610" @default.
- Q96827396 P50 Q74766086 @default.
- Q96827396 P577 "2020-07-01T00:00:00Z" @default.
- Q96827396 P6216 Q50423863 @default.
- Q96827396 P698 "32608142" @default.
- Q96827396 P932 "7543335" @default.